The importance of quality-of-life endpoints in clinical trials to the practicing oncologist.
Saved in:
| Title: | The importance of quality-of-life endpoints in clinical trials to the practicing oncologist. |
|---|---|
| Authors: | Passik SD; Community Cancer Care, Inc., Indianapolis, Indiana, USA., Kirsh KL |
| Source: | Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2000 Aug; Vol. 14 (4), pp. 877-86. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print Cited Medium: Print ISSN: 0889-8588 (Print) Linking ISSN: 08898588 NLM ISO Abbreviation: Hematol Oncol Clin North Am Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
